G Medical Innovations Holdings, which provides app-connected medical devices for monitoring vital signs, announced terms for its US IPO on Monday. The company is currently listed on the ASX under the symbol GMV.
The London, United Kingdom-based company plans to raise $15 million by offering 1.43 million ADSs at a price of $10.50, where it would command a fully diluted market value of $81 million.
G Medical Innovations Holdings was founded in 2014 and booked $3 million in sales for the 12 months ended December 31, 2018. It plans to list on the Nasdaq under the symbol GMVD. H.C. Wainwright is the sole bookrunner on the deal. It is expected to price in June.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.